OpenVSafe by OpenVAERS
Search V-safe

9MR-32564-79678

4 vaccinations 4 coded responses 32 check-ins 4 free-text entries 0 call cases
Sex
Female
Age at first dose
61-65
ZIP prefix
325 / FL
Registered
2021-03-08
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-08
    Registered in v-safe
  2. 2021-03-08
    Dose 1 — Moderna
  3. 2021-03-08
    Survey response — day 0, dose 1
    MedDRA: Injection site pain — Feeling: Good
    Free text: Just sore muscle at injection site.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-03-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Fatigue or tiredness
    Adult check-in
  5. 2021-03-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-03-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Chills, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  7. 2021-03-12
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-03-13
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-03-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-03-15
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  11. 2021-03-22
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-03-29
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-04-05
    Health check-in — day 28, dose 1
    Feeling: Good
    Adult check-in
  14. 2021-04-09
    Dose 2 — Moderna
  15. 2021-04-10
    Survey response — days 1–6 daily, dose 2
    MedDRA: Headache, Injection site reaction — Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: When injection site became really, initially, it came across my neck and to my right shoulder. Next day 4/10/21, gone and just a mild headache.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-04-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  17. 2021-04-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  18. 2021-04-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  19. 2021-04-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  20. 2021-04-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-04-16
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  22. 2021-04-23
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-04-30
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-05-07
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-05-14
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-05-21
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-07-09
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-10-08
    Survey response — 6 months, dose 2
    MedDRA: Ageusia, Anosmia, Blister, COVID-19, Diarrhoea, Eye pain, Fatigue, Ocular hyperaemia, Pain, Visual impairment — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Covid delta variant, slightly achy, extreme fatigue, mild diarrhea, eye pain, red eyes, lost taste and smell. Two weeks after Covid, purple blisters on a toe, finger and face. Also, had some loss of vision.
    MedDRA releases: 2024-11 · check-in free text available
  29. 2021-12-10
    Dose 3 — Pfizer-BioNTech
  30. 2022-04-09
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  31. 2022-09-13
    Dose 4 — Pfizer-BioNTech
    Co-administered: Flu
  32. 2022-10-04
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  33. 2022-10-11
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  34. 2022-10-18
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  35. 2022-10-25
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  36. 2022-12-13
    Survey response — 3 months, dose 4
    MedDRA: Ageusia, Anosmia, Asthenia, Cough, Fatigue, Pulmonary congestion — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Loss of taste and smell. Excessive cough and lung congestion. Fatigue and weakness that lasted around two weeks.
    MedDRA releases: 2024-11 · check-in free text available
  37. 2023-03-14
    Health check-in — 6 months, dose 4
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-08Moderna
22021-04-09Moderna
32021-12-10Pfizer-BioNTech No
42022-09-13Pfizer-BioNTech Flu

Free text

Release 5 — day 0, dose 1

2021-03-08

Systemic reaction (other): Just sore muscle at injection site.

Release 7 — days 1–6 daily, dose 2

2021-04-10

Systemic reaction (other): When injection site became really, initially, it came across my neck and to my right shoulder. Next day 4/10/21, gone and just a mild headache.

Release 10 — 6 months, dose 2

2021-10-08

Symptoms: Covid delta variant, slightly achy, extreme fatigue, mild diarrhea, eye pain, red eyes, lost taste and smell. Two weeks after Covid, purple blisters on a toe, finger and face. Also, had some loss of vision.

Release 12 — 3 months, dose 4

2022-12-13

Symptoms: Loss of taste and smell. Excessive cough and lung congestion. Fatigue and weakness that lasted around two weeks.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAgeusia · · ✓
SDAnosmia · · ✓
SDAsthenia · · ✓
SDBlister · · ✓
SDCough · · ✓
SDCOVID-19 · · ✓
SDDiarrhoea · · ✓
SDEye pain · · ✓
SDFatigue · · ✓
SDOcular hyperaemia · · ✓
SDPain · · ✓
SDPulmonary congestion · · ✓
SDVisual impairment · · ✓
SROHeadache ✓ ✓ ✓
SROInjection site pain ✓ ✓ ✓
SROInjection site reaction ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release